118 related articles for article (PubMed ID: 12580976)
1. Hemolink, an o-raffinose cross-linked haemoglobin-based oxygen carrier, does not affect activation and function of human platelets in whole blood in vitro.
Leytin V; Mazer D; Mody M; Garvey B; Freedman J
Br J Haematol; 2003 Feb; 120(3):535-41. PubMed ID: 12580976
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin-based oxygen carriers do not alter platelet functions: study of three chemically modified hemoglobin solutions.
Toussaint M; Latger-Cannard V; Caron A; Lecompte T; Vigneron C; Menu P
Intensive Care Med; 2003 Jan; 29(1):62-8. PubMed ID: 12528024
[TBL] [Abstract][Full Text] [Related]
3. The intravascular persistence and methemoglobin formation of Hemolink (hemoglobin raffimer) in dogs.
Wicks D; Wong LT; Sandhu R; Stewart RK; Biro GP
Artif Cells Blood Substit Immobil Biotechnol; 2003 Feb; 31(1):1-17. PubMed ID: 12602813
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery.
Cheng DC
Can J Anaesth; 2001 Apr; 48(4 Suppl):S41-8. PubMed ID: 11336436
[TBL] [Abstract][Full Text] [Related]
5. Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's Witness.
Lanzinger MJ; Niklason LE; Shannon M; Hill SE
Can J Anaesth; 2005 Apr; 52(4):369-73. PubMed ID: 15814750
[TBL] [Abstract][Full Text] [Related]
6. Effects of three Hb-based oxygen-carrying solutions on neutrophil activation in vitro: quantitative measurement of the expression of adherence receptors.
Toussaint M; Latger-Cannard V; Caron A; Lecompte T; Stoltz JF; Vigneron C; Menu P
Transfusion; 2001 Feb; 41(2):226-31. PubMed ID: 11239227
[TBL] [Abstract][Full Text] [Related]
7. Human haemoglobin--hemosol: hemolink.
BioDrugs; 2002; 16(3):223-5. PubMed ID: 12102652
[No Abstract] [Full Text] [Related]
8. Vasoconstrictive response of rat mesenteric arterioles following infusion of cross-linked, polymerized, and conjugated hemoglobin solutions.
Caron A; Malfatti E; Aguejouf O; Faivre-Fiorina B; Menu P
Artif Cells Blood Substit Immobil Biotechnol; 2001 Jan; 29(1):19-30. PubMed ID: 11280681
[TBL] [Abstract][Full Text] [Related]
9. Artificial O2 carriers: status in 2005.
Spahn DR; Kocian R
Curr Pharm Des; 2005; 11(31):4099-114. PubMed ID: 16378514
[TBL] [Abstract][Full Text] [Related]
10. The effects of hemodilution with Hemolink upon hemodynamics and blood flow distribution in anesthetized dogs.
Kingma JG; Sandhu R; Hamelin ND; Gendron D; Trudel Y; Bosa M; Stewart R; Fargey MB; Biro GP
Artif Cells Blood Substit Immobil Biotechnol; 2001 Nov; 29(6):465-81. PubMed ID: 11795632
[TBL] [Abstract][Full Text] [Related]
11. A phase I study of oxidized raffinose cross-linked human hemoglobin.
Carmichael FJ; Ali AC; Campbell JA; Langlois SF; Biro GP; Willan AR; Pierce CH; Greenburg AG
Crit Care Med; 2000 Jul; 28(7):2283-92. PubMed ID: 10921554
[TBL] [Abstract][Full Text] [Related]
12. O-raffinose-polymerised haemoglobin. A biochemical and pharmacological profile of an oxygen carrier.
Scatena R; Giardina B
Expert Opin Biol Ther; 2001 Jan; 1(1):121-7. PubMed ID: 11727541
[TBL] [Abstract][Full Text] [Related]
13. A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery.
Cheng DC; Mazer CD; Martineau R; Ralph-Edwards A; Karski J; Robblee J; Finegan B; Hall RI; Latimer R; Vuylsteke A
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):79-86. PubMed ID: 14752416
[TBL] [Abstract][Full Text] [Related]
14. Lactate measurement interference by hemoglobin-based oxygen carriers (Oxyglobin, Hemopure, and Hemolink).
Jahr JS; Osgood S; Rothenberg SJ; Li QL; Butch AW; Gunther R; Cheung A; Driessen B
Anesth Analg; 2005 Feb; 100(2):431-436. PubMed ID: 15673871
[TBL] [Abstract][Full Text] [Related]
15. The novel HemoCu plasma/low hemoglobin system accurately measures small concentrations of three different hemoglobin-based oxygen carriers in plasma: hemoglobin glutamer-200 (bovine) (Oxyglobin), hemoglobin glutamer-250 (bovine) (Hemopure), and hemoglobin-Raffimer (Hemolink).
Lurie F; Jahr JS; Driessen B
Anesth Analg; 2002 Oct; 95(4):870-3, table of contents. PubMed ID: 12351259
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the acute hemodynamic and delayed effects of 50% exchange transfusion with two different cross-linked hemoglobin based oxygen carrying solutions and Pentastarch.
Bonegio RG; Fuhro R; Ragno G; Robert Valeri C; Lieberthal W
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(2):145-57. PubMed ID: 16537171
[TBL] [Abstract][Full Text] [Related]
17. Effect of oxygen affinity and molecular weight of HBOCs on cerebral oxygenation and blood pressure in rats.
Hare GM; Harrington A; Liu E; Wang JL; Baker AJ; Mazer CD
Can J Anaesth; 2006 Oct; 53(10):1030-8. PubMed ID: 16987859
[TBL] [Abstract][Full Text] [Related]
18. Xenon does not affect human platelet function in vitro.
de Rossi LW; Horn NA; Baumert JH; Gutensohn K; Hutschenreuter G; Rossaint R
Anesth Analg; 2001 Sep; 93(3):635-40. PubMed ID: 11524331
[TBL] [Abstract][Full Text] [Related]
19. Effects of hemoglobin vesicles on resting and agonist-stimulated human platelets in vitro.
Wakamoto S; Fujihara M; Abe H; Yamaguchi M; Azuma H; Ikeda H; Takeoka S; Tsuchida E
Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(2):101-11. PubMed ID: 15960075
[TBL] [Abstract][Full Text] [Related]
20. Cross-linked hemoglobin increases fractional reabsorption and GFR in hypoxic isolated perfused rat kidneys.
Baines AD; Christoff B; Wicks D; Wiffen D; Pliura D
Am J Physiol; 1995 Nov; 269(5 Pt 2):F628-36. PubMed ID: 7503228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
